#VisualAbstract BRAF inhibitor and BRAF inhibitor-based combination therapy were tolerable in treating melanoma for a real-world, Chinese population
RelatedReports
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.
